Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001816838-26-000003
Filing Date
2026-03-26
Accepted
2026-03-26 20:00:15
Documents
1
Period of Report
2026-03-24

Document Format Files

Seq Description Document Type Size
1 form4-03262026_080310.html 4  
1 form4-03262026_080310.xml 4 7867
  Complete submission text file 0001816838-26-000003.txt   9494
Mailing Address 12830 EL CAMINO REAL SUITE 400 SAN DIEGO CA 92130
Business Address 12830 EL CAMINO REAL SUITE 400 SAN DIEGO CA 92130 858-558-2871
ACADIA PHARMACEUTICALS INC (Issuer) CIK: 0001070494 (see all company filings)

EIN.: 061376651 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 1020 STONY HILL ROAD SUITE 300 YARDLEY PA 19067
Business Address
Owen Adams Catherine (Reporting) CIK: 0001816838 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-50768 | Film No.: 26800460